Literature DB >> 28455340

Engineering Escherichia coli Nicotinic Acid Mononucleotide Adenylyltransferase for Fully Active Amidated NAD Biosynthesis.

Xueying Wang1,2, Yongjin J Zhou1, Lei Wang1, Wujun Liu1, Yuxue Liu1,2, Chang Peng1,2, Zongbao K Zhao3,4.   

Abstract

NAD and its reduced form NADH function as essential redox cofactors and have major roles in determining cellular metabolic features. NAD can be synthesized through the deamidated and amidated pathways, for which the key reaction involves adenylylation of nicotinic acid mononucleotide (NaMN) and nicotinamide mononucleotide (NMN), respectively. In Escherichia coli, NAD de novo biosynthesis depends on the protein NadD-catalyzed adenylylation of NaMN to nicotinic acid adenine dinucleotide (NaAD), followed by NAD synthase-catalyzed amidation. In this study, we engineered NadD to favor NMN for improved amidated pathway activity. We designed NadD mutant libraries, screened by a malic enzyme-coupled colorimetric assay, and identified two variants, 11B4 (Y84V/Y118D) and 16D8 (A86W/Y118N), with a high preference for NMN. Whereas in the presence of NMN both variants were capable of enabling the viability of cells of E. coli BW25113-derived NAD-auxotrophic strain YJE003, for which the last step of the deamidated pathway is blocked, the 16D8 expression strain could grow without exogenous NMN and accumulated a higher cellular NAD(H) level than BW25113 in the stationary phase. These mutants established fully active amidated NAD biosynthesis and offered a new opportunity to manipulate NAD metabolism for biocatalysis and metabolic engineering.IMPORTANCE Adenylylation of nicotinic acid mononucleotide (NaMN) and adenylylation of nicotinamide mononucleotide (NMN), respectively, are the key steps in the deamidated and amidated pathways for NAD biosynthesis. In most organisms, canonical NAD biosynthesis follows the deamidated pathway. Here we engineered Escherichia coli NaMN adenylyltransferase to favor NMN and expressed the mutant enzyme in an NAD-auxotrophic E. coli strain that has the last step of the deamidated pathway blocked. The engineered strain survived in M9 medium, which indicated the implementation of a functional amidated pathway for NAD biosynthesis. These results enrich our understanding of NAD biosynthesis and are valuable for manipulation of NAD homeostasis for metabolic engineering.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  NAD biosynthesis; cofactor engineering; protein engineering

Mesh:

Substances:

Year:  2017        PMID: 28455340      PMCID: PMC5478990          DOI: 10.1128/AEM.00692-17

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  30 in total

1.  The Escherichia coli NadR regulator is endowed with nicotinamide mononucleotide adenylyltransferase activity.

Authors:  N Raffaelli; T Lorenzi; P L Mariani; M Emanuelli; A Amici; S Ruggieri; G Magni
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Modeling of the bacterial growth curve.

Authors:  M H Zwietering; I Jongenburger; F M Rombouts; K van 't Riet
Journal:  Appl Environ Microbiol       Date:  1990-06       Impact factor: 4.792

3.  Metabolic engineering through cofactor manipulation and its effects on metabolic flux redistribution in Escherichia coli.

Authors:  Ka-Yiu San; George N Bennett; Susana J Berríos-Rivera; Ravi V Vadali; Yea-Tyng Yang; Emily Horton; Fred B Rudolph; Berna Sariyar; Kimathi Blackwood
Journal:  Metab Eng       Date:  2002-04       Impact factor: 9.783

4.  Engineering Escherichia coli for production of functionalized terpenoids using plant P450s.

Authors:  Michelle C Y Chang; Rachel A Eachus; William Trieu; Dae-Kyun Ro; Jay D Keasling
Journal:  Nat Chem Biol       Date:  2007-04-15       Impact factor: 15.040

5.  Extraction and measurement of NAD(P)(+) and NAD(P)H.

Authors:  Suzanne E Kern; Alexa Price-Whelan; Dianne K Newman
Journal:  Methods Mol Biol       Date:  2014

6.  RosettaBackrub--a web server for flexible backbone protein structure modeling and design.

Authors:  Florian Lauck; Colin A Smith; Gregory F Friedland; Elisabeth L Humphris; Tanja Kortemme
Journal:  Nucleic Acids Res       Date:  2010-05-12       Impact factor: 16.971

7.  From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways.

Authors:  Svetlana Y Gerdes; Michael D Scholle; Mark D'Souza; Axel Bernal; Mark V Baev; Michael Farrell; Oleg V Kurnasov; Matthew D Daugherty; Faika Mseeh; Boris M Polanuyer; John W Campbell; Shubha Anantha; Konstantin Y Shatalin; Shamim A K Chowdhury; Michael Y Fonstein; Andrei L Osterman
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

Review 8.  NAD(P) biosynthesis enzymes as potential targets for selective drug design.

Authors:  G Magni; M Di Stefano; G Orsomando; N Raffaelli; S Ruggieri
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Nicotinamide mononucleotide synthetase is the key enzyme for an alternative route of NAD biosynthesis in Francisella tularensis.

Authors:  Leonardo Sorci; Dariusz Martynowski; Dmitry A Rodionov; Yvonne Eyobo; Xhavit Zogaj; Karl E Klose; Evgeni V Nikolaev; Giulio Magni; Hong Zhang; Andrei L Osterman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

10.  Engineering NAD+ availability for Escherichia coli whole-cell biocatalysis: a case study for dihydroxyacetone production.

Authors:  Yongjin J Zhou; Wei Yang; Lei Wang; Zhiwei Zhu; Sufang Zhang; Zongbao K Zhao
Journal:  Microb Cell Fact       Date:  2013-11-09       Impact factor: 5.328

View more
  7 in total

Review 1.  Redox cofactor engineering in industrial microorganisms: strategies, recent applications and future directions.

Authors:  Jiaheng Liu; Huiling Li; Guangrong Zhao; Qinggele Caiyin; Jianjun Qiao
Journal:  J Ind Microbiol Biotechnol       Date:  2018-03-27       Impact factor: 3.346

Review 2.  Engineering natural and noncanonical nicotinamide cofactor-dependent enzymes: design principles and technology development.

Authors:  Edward King; Sarah Maxel; Han Li
Journal:  Curr Opin Biotechnol       Date:  2020-09-18       Impact factor: 9.740

3.  Intensifying niacin-based biosynthesis of NAD+ to enhance 3-hydroxypropionic acid production in Klebsiella pneumoniae.

Authors:  Shimin Wu; Peng Zhao; Qingyang Li; Pingfang Tian
Journal:  Biotechnol Lett       Date:  2020-09-29       Impact factor: 2.461

Review 4.  Synthetic spatial patterning in bacteria: advances based on novel diffusible signals.

Authors:  Martina Oliver Huidobro; Jure Tica; Georg K A Wachter; Mark Isalan
Journal:  Microb Biotechnol       Date:  2021-11-29       Impact factor: 6.575

5.  Metabolic engineering of Escherichia coli for optimized biosynthesis of nicotinamide mononucleotide, a noncanonical redox cofactor.

Authors:  William B Black; Derek Aspacio; Danielle Bever; Edward King; Linyue Zhang; Han Li
Journal:  Microb Cell Fact       Date:  2020-07-27       Impact factor: 5.328

6.  Creating enzymes and self-sufficient cells for biosynthesis of the non-natural cofactor nicotinamide cytosine dinucleotide.

Authors:  Xueying Wang; Yanbin Feng; Xiaojia Guo; Qian Wang; Siyang Ning; Qing Li; Junting Wang; Lei Wang; Zongbao K Zhao
Journal:  Nat Commun       Date:  2021-04-09       Impact factor: 14.919

7.  A de novo peroxidase is also a promiscuous yet stereoselective carbene transferase.

Authors:  Richard Stenner; Jack W Steventon; Annela Seddon; J L Ross Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-02       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.